REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ispotaly Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: ISPOTALY Gyogyszer es Gyogykozmetikai Kereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Ispotaly Bt. is an enterprise in Hungary, with the main office in Debrecen. The company operates in the Pharmacies and Drug Stores industry. It was established on December 27, 1993. 10 (2024) employees currently work for Ispotaly Bt.. In 2023, the company reported a net sales revenue increase of 10.59%. During that time, Ispotaly Bt.’s total assets grew by 11.37%. In 2023, Ispotaly Bt.’s net profit margin increased by 2.61%.

Headquarters
Csigekert utca 7. fszt. 3.
Debrecen; Hajdu-Bihar; Postal Code: 4027

Contact Details: Purchase the Ispotaly Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Ispotaly Bt. report to view the information.
Outstanding Shares:
Purchase the Ispotaly Bt. report to view the information.
Registered Capital:
Purchase the Ispotaly Bt. report to view the information.
Financial Auditors:
Purchase the Ispotaly Bt. report to view the information.
Incorporation Date:
December 27, 1993
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Viridis-Pharma Kft.
Company Performance
Financial values in the chart are available after Ispotaly Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.59%▲
Total operating revenue
10.16%▲
Operating profit (EBIT)
17.25%▲
EBITDA
18.02%▲
Net Profit (Loss) for the Period
33.64%▲
Total assets
11.37%▲
Total equity
-3.34%▼
Operating Profit Margin (ROS)
0.74%▲
Net Profit Margin
2.61%▲
Return on Equity (ROE)
17.81%▲
Quick Ratio
-0.33%▼
Cash Ratio
-1.09%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo